Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Thomas J. Schall

Director at Immuneering Corp (IMRX)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return+15.7%
vs. S&P 500+10.8%
Beat the market100%
Paper profit on buys−$16K
Total bought / sold$101K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Jan 20SEC IMRXImmuneering Corp Buy 21,64574,530 held (+41%) $4.67 $101K -15.6%
  • Buy

    Director Thomas J. Schall bought $101K of IMRX at $4.67 — first open-market purchase in our records; raises the stake by 41%.